Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT00003641Phase 3Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Melanoma (Skin)
StudychairStart date: 1999-03-25

Research Network

Collaboration Network

11 collaborators·24 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Affiliations

UPMC Cancer Center at UPMC Presbyterian

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Show-Li Sun, MD

Astex Pharmaceuticals, Inc.

Moderately Similar
6 trials

Shared therapeutic areas:

Melanoma (Skin)
Similarity Score30%

Sabine Hazan, MD

ProgenaBiome

Moderately Similar
41 trials

Shared therapeutic areas:

Melanoma (Skin)
Similarity Score30%

Antoni Ribas, MD

Jonsson Comprehensive Cancer Center

Moderately Similar
5 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Jeffrey A. Sosman, MD

Vanderbilt-Ingram Cancer Center

Moderately Similar
6 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Similarity Score30%

Ralph Hauke, MD

University of Nebraska

Moderately Similar
6 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Jeffrey S. Weber, MD, PhD

University of Southern California

Moderately Similar
9 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Similarity Score30%

Ulka N. Vaishampayan, MD

Barbara Ann Karmanos Cancer Institute

Moderately Similar
6 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Similarity Score30%

Thomas F. Gajewski, MD, PhD

University of Chicago

Moderately Similar
5 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

John A. Thompson, MD

Seattle Cancer Care Alliance

Moderately Similar
4 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

Cancer and Leukemia Group BChildren's Oncology Group+2 more
Similarity Score30%

Lauren E. Abrey, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
8 trials

Shared therapeutic areas:

Melanoma (Skin)

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00003641Phase 3StudyChair

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Melanoma (Skin)
Completed

All 1 trials loaded